The long-term objective of our research centers on elucidation of the mechanisms whereby critical cell cycle 'regulators contribute to the genesis and progression of neoplastic transformation. Much of our current work focuses on how the contribution of regulated, ubiquitin-dependent destruction of cyclin D1 for normal versus neoplastic growth. The noted overexpression of cyclin D1 in more than 50% of human esophageal cancer highlights the importance of elucidating the mechanisms that regulate cyclin D1 activity in this deadly cancer. While cyclin D1 overexpression is a consequence of gene amplification and chromosome translocation in a subset of cancers, decreased cyclin D1 protein degradation, which depends on its phosphorylation of Thr286, is thought to be the key factor in a majority of esophageal cancers. We have recently identified the SCF(Fbx4-aB crystallin) as the E3 ubiquitin ligase that controls cyclin D1 ubiquitination and degradation. This critical discovery has provided essential information and tools necessary to assess the mechanisms that contribute to regulation of cyclin D1 accumulation during malignant progression. More importantly, our recent discovery of inactivating mutations in Fbx4 in esophageal cancer strongly supports our hypothesis that Fbx4 functions as a novel tumor suppressor gene. The identification of this E3 ligase as well as our recent preliminary studies lead to the overarching hypothesis that the SCF(Fbx4 aB crystallin) ligase via coordinated recognition of phospho-cyclin D1 by Fbx4 and aB crystallin, plays a critical role in the maintenance of esophageal cell proliferation, and trasformation. The hypothesis will be pursued by the (following interrelated Specific Aims: 1) To define the post-translational regulation of cyclin D1 by Fbx4 as it pertains to ligase function, utilizing esophageal cancer derived mutations as a guide;2) To determine the contribution of Fbx4 to esophageal tissue homeostasis and transformation in vivo and in vitro;and 3) To evaluate the role of Fbx4 in maintenance of genomic stability and response of tumor cells to cheomtherapeutic intervention. Project 3 is closely integrated with Project 1 (Aims 1 and 2) and Project 2 (Aim 2), and utilizes all the outstanding cores.
This Project has made fundamental new discoveries in the regulation of cyclin D1, often overexpressed in esophageal squamous cell cancer. To that end, Fbx4, part of the E3 ligase that regulates cyclin D1, is mutated in this cancer. This has applications in molecular-clinical correlations for cancer prognosis, and developing new strategies for controlling cell cycle regulation and DMA damage responses.
|Tetreault, Marie-Pier; Weinblatt, Daniel; Shaverdashvili, Khvaramze et al. (2016) KLF4 transcriptionally activates non-canonical WNT5A to control epithelial stratification. Sci Rep 6:26130|
|Yoshida, Akihiro; Lee, Eric K; Diehl, J Alan (2016) Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6. Cancer Res 76:2990-3002|
|Kong, Jianping; Whelan, Kelly A; LaczkÃ³, Dorottya et al. (2016) Autophagy levels are elevated in barrett's esophagus and promote cell survival from acid and oxidative stress. Mol Carcinog 55:1526-1541|
|Dotto, G Paolo; Rustgi, Anil K (2016) Squamous Cell Cancers: A Unified Perspective on Biology and Genetics. Cancer Cell 29:622-37|
|Qie, Shuo; Diehl, J Alan (2016) Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med (Berl) 94:1313-1326|
|TÃ©treault, Marie-Pier; Weinblatt, Daniel; Ciolino, Jody Dyan et al. (2016) Esophageal Expression of Active IÎºB Kinase-Î² in MiceÂ Up-Regulates Tumor Necrosis Factor and Granulocyte-Macrophage Colony-Stimulating Factor, PromotingÂ Inflammation and Angiogenesis. Gastroenterology 150:1609-1619.e11|
|Whelan, Kelly A; Merves, Jamie F; Giroux, Veronique et al. (2016) Autophagy mediates epithelial cytoprotection in eosinophilic oesophagitis. Gut :|
|Lin, E W; Karakasheva, T A; Hicks, P D et al. (2016) The tumor microenvironment in esophageal cancer. Oncogene 35:5337-5349|
|Shearin, Abigail L; Monks, Bobby R; Seale, Patrick et al. (2016) Lack of AKT in adipocytes causes severe lipodystrophy. Mol Metab 5:472-9|
|Facompre, Nicole D; Harmeyer, Kayla M; Sole, Xavier et al. (2016) JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers. Cancer Res 76:5538-49|
Showing the most recent 10 out of 139 publications